ARTICLE | Company News
Alcyone Lifesciences, Lysogene deal
September 7, 2015 7:00 AM UTC
Lysogene and Alcyone partnered to evaluate the intraparenchymal delivery of Lysogene’s recombinant adeno-associated virus (rAAV) to treat patients with mucopolysaccharidosis IIIA (MPS IIIA, Sanfilipp...